Virtu Financial LLC P Lx Pharma Inc. Transaction History

Virtu Financial LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 01, 2023	SELL	$0.12 - $0.3 $3,790 - $9,475	-31,584 Reduced 44.26%	39,784 $5,000
Q4 2022 Feb 15, 2023	BUY	$0.15 - $0.63 $10,705 - $44,961	71,368 New	71,368 $12,000
Q1 2022 May 17, 2022	SELL	$3.54 - $8.3 $46,154 - $108,215	-13,038 Closed	0 $0
Q4 2021 Feb 17, 2022	BUY	$7.69 - $19.66 $100,262 - $256,327	13,038 New	13,038 $104,000

62.7K

Ticker PLXP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,137,700
Description
PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other asp...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.